APA (7th ed.) Citation

J, I., Z, W., S, P., C, O., M, M., B, M., . . . AS, M. (2004). Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity. Cancer gene therapy, 11(3), 174. https://doi.org/10.1038/sj.cgt.7700666

Chicago Style (17th ed.) Citation

J, Irving, Wang Z, Powell S, O'Sullivan C, Mok M, Murphy B, Cardoza L, Lebkowski JS, and Majumdar AS. "Conditionally Replicative Adenovirus Driven by the Human Telomerase Promoter Provides Broad-spectrum Antitumor Activity Without Liver Toxicity." Cancer Gene Therapy 11, no. 3 (2004): 174. https://doi.org/10.1038/sj.cgt.7700666.

MLA (9th ed.) Citation

J, Irving, et al. "Conditionally Replicative Adenovirus Driven by the Human Telomerase Promoter Provides Broad-spectrum Antitumor Activity Without Liver Toxicity." Cancer Gene Therapy, vol. 11, no. 3, 2004, p. 174, https://doi.org/10.1038/sj.cgt.7700666.